Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/s41415-023-6144-7 | DOI Listing |
Br Dent J
July 2023
Manchester University NHS Foundation Trust, Manchester, United Kingdom.
PLoS One
July 2018
Strategy and Business Policy, HEC Paris, Jouy-en-Josas, France.
The present investigation modeled the emergence and persistence of intergroup bias and discrimination in artificial societies. Initial unfair prejudices held by members of a dominant group elicit confirmatory behavior (diminished cooperation) from members of a subordinate group via a self-fulfilling prophecy. Further, when individual learning is tempered by conformity to peers, inaccurate beliefs about the stigmatized subordinate group persist long-term.
View Article and Find Full Text PDFAdv Med
November 2015
Department of Pharmacology, Government Medical College, Amritsar 143001, India.
Introduction. Drug promotional advertisements (DPAs) form a major marketing technique of pharmaceutical companies for promoting their products and disseminating ambiguous drug information which can affect prescribing pattern of physicians. Drug information includes product characteristics, various marketing claims with references in support to increase its credibility and authenticity.
View Article and Find Full Text PDFCochrane Database Syst Rev
March 2013
Heart Center, Ghent University Hospital, Ghent, Belgium.
Background: Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined.
View Article and Find Full Text PDFCochrane Database Syst Rev
January 2008
Ghent University, Heymans Institute of Pharmacology, De Pintelaan 185, Gent, Belgium B-9000.
Background: Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!